Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists

Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists

The paper considers arterial hypertension and coronary heart disease as pathologies which share multiple pathogenetic mechanisms. The role of angiotensin II receptor antagonists (ARA) in the effective treatment of these diseases and in prevention of their complications is discussed. The modern views...

Full description

Bibliographic Details
Main Author:	E. O. Taratukhin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atherosclerosis haemostasis platelets losartan
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2032

Similar Items

DISORDERS OF PLASMA AND PLATELET PATHWAYS OF HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH DISLIPOPROTEINEMIA
by: M. Y. Zhuk, et al.
Published: (2003-10-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

The effects of acute administration of losartan, angiotensin II type-1 receptor antagonist, on hemodynamics and oxidative stress parameters in malignant hypertensive rats
by: Bogunović Natalija, et al.
Published: (2015-01-01)

Angiotensin II receptor antagonists – we have moved closer to the patient
by: L. G. Ratova, et al.
Published: (2005-04-01)

The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension
by: N Sh Zagidullin, et al.
Published: (2009-12-01)

Effects of the Angiotensin II Antagonist, Losartan, on Circulo-Respiratory Responses to Submaximal Exercise in Hypertensive Women
by: Craft, Laura Lee III
Published: (2014)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat
by: Ciobica Alin, et al.
Published: (2011-06-01)

Angiotensin II type 1 receptor is involved in hypertension and vascular alterations caused by environmental toxicant hexachlorobenzene
by: Giselle Romero Caimi, et al.
Published: (2021-01-01)

Difficult choice: angiotensin receptor antagonists
by: E. O. Taratukhin
Published: (2013-04-01)

Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome
by: S V Nedogoda, et al.
Published: (2013-06-01)

The Angiotensin II Type 1 Receptor Antagonist Losartan Affects NHE1-Dependent Melanoma Cell Behavior
by: Daniel Navin Olschewski, et al.
Published: (2018-03-01)

CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS
by: V. S. Zadionchenko, et al.
Published: (2015-12-01)

Ultrastructural features of platelets in the patients with diabetes mellitus type 2 in a decompensation with arterial hypertension under correction of arterial blood pressure with losartan
by: Pertseva N.O.
Published: (2012-01-01)

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl4-Induced Skeletal Muscle Injury
by: Ok-Kyung Hwang, et al.
Published: (2016-02-01)

Endogenous angiotensin II modulates nNOS expression in renovascular hypertension
by: T.M.C. Pereira, et al.
Published: (2009-07-01)

LYMPHOCYTE-TO PLATELET ADHERENCE IN PATIENTS WITH ERYSIPELAS
by: A. N. Emelyanova, et al.
Published: (2014-07-01)

Quantitative morphological characteristics of intravascular platelet activity in patients with diabetes mellitus type 2 with arterial hypertension under losartan treatment
by: Dzyak G.V., et al.
Published: (2012-01-01)

Haemostasis – issue always up todate
by: Eliza Pleban
Published: (2015-06-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Quantitative ultrastructural characteristics of platelets in the patients with diabetes mellitus type 2 in a compensation with arterial hypertension under correction of arterial blood pressure with losartan
by: Pertseva N.O.
Published: (2011-01-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Protective role of angiotensin Type 1 receptor blockade in 4/6 nephrectomized male and female rats
by: Maryam Moeini, et al.
Published: (2019-01-01)

Effects of Omega-3 Polyunsaturated Fatty Acids and Their Metabolites on Haemostasis—Current Perspectives in Cardiovascular Disease
by: Jacek Golanski, et al.
Published: (2021-02-01)

Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non‐small‐cell lung cancer
by: Long T. Hoang, et al.
Published: (2019-11-01)

Synthetic Flavonoids as Novel Modulators of Platelet Function and Thrombosis
by: Thomas M. Vallance, et al.
Published: (2019-06-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

RENIN-ANGIOTENSIN PROFILE AND COMPARATIVE EFFECTIVENESS OF FIRST-LINE MEDICATIONS IN MONOTHERAPY OF ESSENTIAL ARTERIAL HYPERTENSION
by: Sh. V. Akhadov, et al.
Published: (2010-06-01)

PREDICTING PRECLINICAL THROMBOGENIC ABNORMALITIES IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
by: S. S. Bunova, et al.
Published: (2013-04-01)

Place of arterial hypertension in brain lesion development - from minor cognitive disorders to dementia
by: V N Shishkova
Published: (2014-03-01)

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Comparative effectiveness of original and generic losartan in patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-12-01)

Dynamics of morphological changes of platelet granules in patients with hypertension and high cardiovascular risk in applying losartan potassium
by: Tverdokhleb I.V., et al.
Published: (2014-06-01)

Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension
by: I V Butorov, et al.
Published: (2004-06-01)

Platelet and Thrombophilia-Related Risk Factors of Retinal Vein Occlusion
by: Adrianna Marcinkowska, et al.
Published: (2021-07-01)

LOW LEVEL OF ANTITHROMBIN III AS A WARNING SIGN FOR DEVELOPING THROMBOTIC COMPLICATIONS IN SURGICAL PATIENTS
by: K. N. Zolotukhin, et al.
Published: (2018-08-01)

Antithrombotic Potential of Tormentil Extract in Animal Models
by: Natalia Marcinczyk, et al.
Published: (2017-08-01)

Mechanochemistry of von Willebrand factor
by: Lancellotti Stefano, et al.
Published: (2019-11-01)